Pharmacological treatment of asthma in Sweden from 2005 to 2015

CONCLUSIONS: The use of ICS + LABA both for maintenance treatment and symptom relief has increased over time. Despite this, the problem of low use of ICS and high use of SABA remains.PMID:37910450 | DOI:10.1080/02770903.2023.2272798

Source: Journal of Asthma - November 1, 2023 Category: Respiratory Medicine Authors: Caroline Ahlroth Pind Bj örn Ställberg Karin Lisspers Josefin Sundh Marta A Kisiel Hanna Sandelowsky Anna Nager Mikael Hasselgren Scott Montgomery Christer Janson Source Type: research